Lumos Diagnostics Holdings Ltd.ASX: LDX

Lumos Secures Distribution for FebriDx in Portugal

· Issued by Lumos Diagnostics Holdings Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Lumos Diagnostics Holdings Ltd. has announced a new distribution agreement for FebriDx in Portugal with Magnamed LDA. Magnamed is a medical device distributor that supplies various healthcare facilities in Portugal. This partnership aims to enhance access to FebriDx across the Portuguese market, leveraging Magnamed's established logistics and customer relationships. Lumos is expanding its European distribution network, with existing agreements in several countries already in place.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT Lumos Secures Distribution for FebriDx® in Portugal MELBOURNE, Australia (19 November 2026) – Lumos Diagnostics Holdings Ltd (ASX:LDX, “Lumos” or the “Company”) a leader in rapid, point-of-care diagnostic technologies, is pleased to announce that it has executed a new...

Lumos Diagnostics Holdings Ltd. on 6ix

Story so far

Earlier from Lumos Diagnostics

All Lumos Diagnostics news releases